Beth LeBow
Lawyers
Associate in our Corporate practice, based in Northern California.
Experience highlights
Recent Representations
- RayzeBio $358 million IPO
- CSG Systems International $425 million convertible senior notes offering
- ACELYRIN $621 million IPO
- Enovix $162.5 million convertible senior notes and capped call transactions
- Revolution Medicines $345 million follow-on offering
- Tenaya Therapeutics $75 million stock and pre-funded warrants offering
- Natera $400 million follow-on offering
- Elon Musk $13.2 billion Twitter acquisition financing
- IDEAYA Biosciences $92 million follow-on offering
- Tenaya Therapeutics $75 million at-the-market offering
- RxSight $50 million at-the-market offering
- Cryoport $403 million notes offering and concurrent $249 million stock offering
- Aligos Therapeutics $75 million at-the-market offering
- ForgeRock $316 million IPO
- Ingram Micro $7.2 billion acquisition by Platinum Equity
- Aligos Therapeutics $83.6 million follow-on offering
Education
J.D., Stanford Law School
- Member, Stanford Law Review
B.S., Animal Science, Cornell University
- summa cum laude
- with distinction in research
Professional history
- Davis Polk since 2017
Qualifications and admissions
- State of California